FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143642806> ?p ?o ?g. }

• W2143642806 endingPage "797" @default.
• W2143642806 startingPage "789" @default.
• W2143642806 abstract "New approaches are focusing on using a combination of medication that lyse fibrin and prevent aggregation of platelets to achieve higher rates of recanalization and improved clinical outcomes.A prospective, nonrandomized, open-label trial evaluated the safety of an escalating dose of reteplase in conjunction with intravenous abciximab (platelet glycoprotein IIb/IIIa inhibitor) in patients with acute ischemic stroke (3-6 h after symptom onset). The primary endpoint was symptomatic intracerebral hemorrhage at 24 to 72 hours, and secondary endpoints were partial or complete recanalization (> or = one grade improvement), early neurological improvement (decrease in National Institutes of Health Stroke Scale > or = 4 at 24 h), and favorable outcome at 1 month (defined by modified Rankin scale < or = 2).A total of 20 patients (mean age, 65 yr; 13 men) were recruited. Five patients were recruited in each of the escalating tiers of intra-arterial reteplase (0.5, 1, 1.5, and 2 units). Intravenous abciximab (0.25 mg/kg bolus followed by 0.125 mug/kg/min) was successfully administered in 18 out of 20 patients. The safety stopping rule was not activated in any of the tiers. One symptomatic intracerebral hemorrhage was observed in one of the 20 patients (in the 1-unit tier). Partial or complete recanalization was observed in 13 of the 20 patients. Thirteen patients demonstrated early neurological improvement, and favorable outcome at 1 month was observed in six patients.In this study, a combination of intra-arterial reteplase and intravenous abciximab was safely administered to patients with ischemic stroke presenting between 3 and 6 hours after symptom onset." @default.
• W2143642806 created "2016-06-24" @default.
• W2143642806 creator A5000156377 @default.
• W2143642806 creator A5000410497 @default.
• W2143642806 creator A5000640102 @default.
• W2143642806 creator A5006733279 @default.
• W2143642806 creator A5024499278 @default.
• W2143642806 creator A5036895407 @default.
• W2143642806 creator A5047427155 @default.
• W2143642806 creator A5083072999 @default.
• W2143642806 date "2006-10-01" @default.
• W2143642806 modified "2023-10-10" @default.
• W2143642806 title "Intra-arterial Reteplase and Intravenous Abciximab in Patients with Acute Ischemic Stroke: An Open-label, Dose-ranging, Phase I Study" @default.
• W2143642806 cites W1242868768 @default.
• W2143642806 cites W184119209 @default.
• W2143642806 cites W1963521352 @default.
• W2143642806 cites W1972109636 @default.
• W2143642806 cites W1983126671 @default.
• W2143642806 cites W1984168123 @default.
• W2143642806 cites W1995462255 @default.
• W2143642806 cites W2012316898 @default.
• W2143642806 cites W2017069772 @default.
• W2143642806 cites W2036341664 @default.
• W2143642806 cites W2036707395 @default.
• W2143642806 cites W2039160954 @default.
• W2143642806 cites W2087937646 @default.
• W2143642806 cites W2090655685 @default.
• W2143642806 cites W2106186734 @default.
• W2143642806 cites W2111977341 @default.
• W2143642806 cites W2119169574 @default.
• W2143642806 cites W2125478367 @default.
• W2143642806 cites W2130010725 @default.
• W2143642806 cites W2292308933 @default.
• W2143642806 cites W2316461329 @default.
• W2143642806 cites W2317947810 @default.
• W2143642806 cites W2342256744 @default.
• W2143642806 cites W2413086606 @default.
• W2143642806 cites W3022148767 @default.
• W2143642806 cites W4229918821 @default.
• W2143642806 cites W4231815458 @default.
• W2143642806 doi "https://doi.org/10.1227/01.neu.0000232862.06246.3d" @default.
• W2143642806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16915119" @default.
• W2143642806 hasPublicationYear "2006" @default.
• W2143642806 type Work @default.
• W2143642806 sameAs 2143642806 @default.
• W2143642806 citedByCount "79" @default.
• W2143642806 countsByYear W21436428062012 @default.
• W2143642806 countsByYear W21436428062013 @default.
• W2143642806 countsByYear W21436428062014 @default.
• W2143642806 countsByYear W21436428062015 @default.
• W2143642806 countsByYear W21436428062016 @default.
• W2143642806 countsByYear W21436428062017 @default.
• W2143642806 countsByYear W21436428062018 @default.
• W2143642806 countsByYear W21436428062020 @default.
• W2143642806 countsByYear W21436428062022 @default.
• W2143642806 crossrefType "journal-article" @default.
• W2143642806 hasAuthorship W2143642806A5000156377 @default.
• W2143642806 hasAuthorship W2143642806A5000410497 @default.
• W2143642806 hasAuthorship W2143642806A5000640102 @default.
• W2143642806 hasAuthorship W2143642806A5006733279 @default.
• W2143642806 hasAuthorship W2143642806A5024499278 @default.
• W2143642806 hasAuthorship W2143642806A5036895407 @default.
• W2143642806 hasAuthorship W2143642806A5047427155 @default.
• W2143642806 hasAuthorship W2143642806A5083072999 @default.
• W2143642806 hasConcept C126322002 @default.
• W2143642806 hasConcept C127413603 @default.
• W2143642806 hasConcept C141071460 @default.
• W2143642806 hasConcept C17624336 @default.
• W2143642806 hasConcept C203092338 @default.
• W2143642806 hasConcept C2776336681 @default.
• W2143642806 hasConcept C2777094939 @default.
• W2143642806 hasConcept C2777871224 @default.
• W2143642806 hasConcept C2780645631 @default.
• W2143642806 hasConcept C2780790693 @default.
• W2143642806 hasConcept C2780931571 @default.
• W2143642806 hasConcept C3020199598 @default.
• W2143642806 hasConcept C42219234 @default.
• W2143642806 hasConcept C45393284 @default.
• W2143642806 hasConcept C500558357 @default.
• W2143642806 hasConcept C535046627 @default.
• W2143642806 hasConcept C541997718 @default.
• W2143642806 hasConcept C71924100 @default.
• W2143642806 hasConcept C78519656 @default.
• W2143642806 hasConceptScore W2143642806C126322002 @default.
• W2143642806 hasConceptScore W2143642806C127413603 @default.
• W2143642806 hasConceptScore W2143642806C141071460 @default.
• W2143642806 hasConceptScore W2143642806C17624336 @default.
• W2143642806 hasConceptScore W2143642806C203092338 @default.
• W2143642806 hasConceptScore W2143642806C2776336681 @default.
• W2143642806 hasConceptScore W2143642806C2777094939 @default.
• W2143642806 hasConceptScore W2143642806C2777871224 @default.
• W2143642806 hasConceptScore W2143642806C2780645631 @default.
• W2143642806 hasConceptScore W2143642806C2780790693 @default.
• W2143642806 hasConceptScore W2143642806C2780931571 @default.
• W2143642806 hasConceptScore W2143642806C3020199598 @default.
• W2143642806 hasConceptScore W2143642806C42219234 @default.
• W2143642806 hasConceptScore W2143642806C45393284 @default.
• W2143642806 hasConceptScore W2143642806C500558357 @default.

• next